OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
This is a summary curated by AIFuture. Read the complete article at the original source:
Read the full story on TechCrunch